| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $0.72 (Miss by $-0.011) |
| EPS GAAP Actual | $0.72 (Miss by $-0.011) |
| Revenue Actual | $2.062B |
| Revenue Surprise | Beat by $2062M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2029 | 4.24 | 13.6 | 4.16116 | 4.39267 | 2 |
| Jan 2029 | 4.24 | 13.6 | 4.1578 | 4.31083 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.72 | 0.72 | 2.062B | 1.16% | 2062M |
| FQ3 2025 (Aug 2025) | 0 | 0 | 2.093B | 100% | 2093M |
| FQ2 2019 (Apr 2019) | 0.0131 | 0.0131 | 0.7793B | 100% | 779.3M |
| FQ3 2019 (Jul 2019) | 0.17 | 0.17 | 0.924B | 100% | 924M |
| FQ4 2019 (Oct 2019) | 0.15 | 0.15 | 0.9521B | 100% | 952.1M |
| FQ1 2020 (Jan 2020) | -0.08 | -0.08 | 0.7332B | 100% | 733.2M |
| FQ2 2025 (May 2025) | 0.53 | 0.53 | 1.911B | 100% | 1911M |
| FQ1 2025 (Feb 2025) | 0.35 | 0.35 | 1.698B | 100% | 1698M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 0.66113 | -- | 0.64505 | 0.6733 | 1 |
| FQ4 2027 (Nov 2027) | 1.11088 | -- | 1.08386 | 1.13132 | 1 |
| FQ3 2027 (Aug 2027) | 1.11284 | -- | 1.08578 | 1.13332 | 1 |
| FQ2 2027 (May 2027) | 0.81071 | -- | 0.79099 | 0.82563 | 1 |
| FQ1 2027 (Feb 2027) | 0.42671 | -- | 0.41983 | 0.43483 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 1.75B | -- | 1.71B | 1.77B | 1 |
| FQ4 2027 (Nov 2027) | 2.26B | -- | 2.22B | 2.3B | 2 |
| FQ3 2027 (Aug 2027) | 2.25B | -- | 2.21B | 2.28B | 2 |
| FQ2 2027 (May 2027) | 1.98B | -- | 1.94B | 2B | 2 |
| FQ1 2027 (Feb 2027) | 1.68B | -- | 1.66B | 1.71B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.72 | 0.72 | 100% | |
| FQ3 2025 (Aug 2025) | 0 | 0 | NAN% | |
| FQ2 2019 (Apr 2019) | 0.0131 | 0.0131 | 100% | |
| FQ3 2019 (Jul 2019) | 0.17 | 0.17 | 100% | |
| FQ4 2019 (Oct 2019) | 0.15 | 0.15 | 100% | |
| FQ1 2020 (Jan 2020) | -0.08 | -0.08 | 100% | |
| FQ2 2025 (May 2025) | 0.53 | 0.53 | 100% | |
| FQ1 2025 (Feb 2025) | 0.35 | 0.35 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $2.06B | $2062M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $2.09B | $2093M | 100% |
| FQ2 2019 (Apr 2019) | $0B | $0.78B | $779.3M | 100% |
| FQ3 2019 (Jul 2019) | $0B | $0.92B | $924M | 100% |
| FQ4 2019 (Oct 2019) | $0B | $0.95B | $952.1M | 100% |
| FQ1 2020 (Jan 2020) | $0B | $0.73B | $733.2M | 100% |
| FQ2 2025 (May 2025) | $0B | $1.91B | $1911M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $1.7B | $1698M | 100% |